Skip to main content
. Author manuscript; available in PMC: 2009 Jun 8.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2007 Dec 31;71(2):401–406. doi: 10.1016/j.ijrobp.2007.10.031

Table 1.

Patient characteristics

All Nasal Cavity Nasal Septum p value
N=68 (%) N=37 (54) N=31 (46)
Gender
 Male 42 (62) 20 (54) 22 (71) 0.15
 Female 26 (38) 17 (46) 9 (29)
Age
 Median 58.5 yrs 57 yrs 63 yrs 0.02
 Range 19–93 yrs 19–93 yrs 43–78 yrs
Histology
 SCC* 45 (66) 19 (51) 26 (84) 0.004
 Others** 23 (34) 18 (49) 5 (16)
Parsons’ clinical stage
 1 33 (48) 13 (36) 20 (67) 0.031
 2 23 (34) 15 (42) 8 (27)
 3 10 (15) 8 (22) 2 (7)
 N/A 2 (3)
AJCC T stage
 T1 20 (29) 6 (16) 14 (45) 0.063
 T2 21 (31) 13 (35) 8 (26)
 T3 9 (13) 5 (14) 4 (13)
 T4 14 (21) 11 (30) 3 (10)
 Tx 4 (6) 2 (5) 2 (6)
Treatment
 RT Alone 32 (47) 11 (30) 21(68)
 Pre-Op RT 3 (4) 3 (8) --
 Post-Op RT 33 (49) 23 (62) 10 (32) 0.01
Smoking
 Yes 41 (60) 22 (60) 19 (61) 0.93
 No 10 (15) 6 (16) 4 (13)
 Unknown 17 (25) 9 (24) 8 (26)
Neck nodes
 Positive 6 (9) 3 (8) 3 (10) 0.13
 Negative 62 (91) 34 (92) 28 (90)
Tumor grade
 Well diff. 8 (12) 5 (13) 3 (10) 0.47
 Mod diff. 9 (13) 3 (8) 6 (19)
 Poor diff. 18 (26) 9 (24) 9 (29)
 Not specified 33 (49) 20 (54) 13 (42)
*

SCC: Squamous cell carcinoma

**

Others include patients with salivary gland histology, adenoid cystic carcinoma (n=12), adenocarcinoma (n=8), and undifferentiated/poorly differentiated carcinoma (n=3).